Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ).

TitleCancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ).
Publication TypeJournal Article
Year of Publication2018
AuthorsCallahan SJ, Tepan S, Zhang YM, Lindsay H, Burger A, Campbell NR, Kim IS, Hollmann TJ, Studer L, Mosimann C, White RM
JournalDis Model Mech
Volume11
Issue9
Date Published2018 09 27
ISSN1754-8411
KeywordsAging, Animals, Animals, Genetically Modified, Carcinogenesis, CRISPR-Cas Systems, Disease Models, Animal, Disease Progression, Electroporation, Embryo, Nonmammalian, Gene Transfer Techniques, Melanoma, Plasmids, Promoter Regions, Genetic, Transgenes, Zebrafish
Abstract

Transgenic animals are invaluable for modeling cancer genomics, but often require complex crosses of multiple germline alleles to obtain the desired combinations. Zebrafish models have advantages in that transgenes can be rapidly tested by mosaic expression, but typically lack spatial and temporal control of tumor onset, which limits their utility for the study of tumor progression and metastasis. To overcome these limitations, we have developed a method referred to as Transgene Electroporation in Adult Zebrafish (TEAZ). TEAZ can deliver DNA constructs with promoter elements of interest to drive fluorophores, oncogenes or CRISPR-Cas9-based mutagenic cassettes in specific cell types. Using TEAZ, we created a highly aggressive melanoma model via Cas9-mediated inactivation of Rb1 in the context of BRAF in spatially constrained melanocytes. Unlike prior models that take ∼4 months to develop, we found that TEAZ leads to tumor onset in ∼7 weeks, and these tumors develop in fully immunocompetent animals. As the resulting tumors initiated at highly defined locations, we could track their progression via fluorescence, and documented deep invasion into tissues and metastatic deposits. TEAZ can be deployed to other tissues and cell types, such as the heart, with the use of suitable transgenic promoters. The versatility of TEAZ makes it widely accessible for rapid modeling of somatic gene alterations and cancer progression at a scale not achievable in other systems.

DOI10.1242/dmm.034561
Alternate JournalDis Model Mech
PubMed ID30061297
PubMed Central IDPMC6177007
Grant ListDP2 CA186572 / CA / NCI NIH HHS / United States
K08 AR055368 / AR / NIAMS NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
F99 CA212436 / CA / NCI NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
F31 CA196305 / CA / NCI NIH HHS / United States